Arkolith/Insider Trading/RIGL/Form 4

Rodriguez Raul R

CEO, President, DirectorRIGEL PHARMACEUTICALS INC (RIGL) · full profile →Form 4 · filed Feb 4, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2026Tax withholding(F)14K$36.01$508K236K
Jan 26, 2026Tax withholding(F)35K$37.00$1.3M250K
Jan 26, 2026Option exercise(M)40K$27.40$1.1M285K
Jan 26, 2026Option exercise(M)40K$27.40$1.1M280K
Jan 26, 2026Tax withholding(F)35K$37.00$1.3M245K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2026Option exercise(M)40K—$00
Jan 26, 2026Option exercise(M)40K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000495) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML